Iqvia Holdings Inc (NYSE:IQV) has received an average rating of “Buy” from the eighteen brokerages that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, thirteen have given a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $139.29.
IQV has been the subject of a number of recent research reports. Goldman Sachs Group upgraded Iqvia from a “buy” rating to a “conviction-buy” rating in a report on Friday, January 11th. Jefferies Financial Group upgraded Iqvia from a “hold” rating to a “buy” rating and boosted their price objective for the company from $136.00 to $150.00 in a report on Friday, January 18th. Royal Bank of Canada boosted their price objective on Iqvia to $137.00 and gave the company an “outperform” rating in a report on Tuesday, October 23rd. Barclays boosted their price objective on Iqvia from $130.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, October 23rd. Finally, Piper Jaffray Companies boosted their price objective on Iqvia to $131.00 and gave the company a “neutral” rating in a report on Tuesday, October 23rd.
In other news, major shareholder Canada Pension Plan Investment sold 3,164,388 shares of the business’s stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $123.72, for a total value of $391,498,083.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronald A. Rittenmeyer sold 3,840 shares of the business’s stock in a transaction on Tuesday, February 5th. The stock was sold at an average price of $130.00, for a total value of $499,200.00. The disclosure for this sale can be found here. Insiders sold a total of 6,751,273 shares of company stock valued at $835,335,596 over the last quarter. Company insiders own 6.00% of the company’s stock.
Shares of Iqvia stock traded up $2.04 on Tuesday, reaching $131.14. The company had a trading volume of 48,041 shares, compared to its average volume of 1,153,382. The stock has a market cap of $25.77 billion, a price-to-earnings ratio of 30.05, a price-to-earnings-growth ratio of 1.59 and a beta of 0.88. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.09 and a current ratio of 1.09. Iqvia has a 1 year low of $91.57 and a 1 year high of $139.65.
Iqvia Company Profile
IQVIA Holdings Inc provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
Read More: Cost of Capital Explained
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.